drugset / Trial / NCT03020810

Dupilumab Compassionate Use Study

NCT03020810 ↗

Expanded access Approved for marketing Sally E. Wenzel MD

Summary

This is a single patient expanded access, compassionate and non-emergency use study that provides patients with severe asthma, who do not qualify for ongoing clinical trials with dupilumab, access to this investigational treatment.

Timeline

Start
—
Primary completion
—
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject Dupilumab Monoclonal antibody 300 mg Subcutaneous

Indications